WARPTECHNEWS · LAB

Home AI Business Tech Archive

Storia: Eli Lilly's Foundayo weight-loss pill approved in the U.K. — Warptech Lab News

Storia in 13 fonti

Eli Lilly's Foundayo weight-loss pill approved in the U.K.

The U.K. regulator authorized orforglipron for weight management and type 2 diabetes, making Britain the first country in Europe to clear the drug

Raccontata da

independent.co.uk

valor.globo.com

economictimes.indiatimes.com

ansa.it+1 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

qz.comStai leggendo1 g fa

Eli Lilly's Foundayo weight-loss pill approved in the U.K.

The U.K. regulator authorized orforglipron for weight management and type 2 diabetes, making Britain the first country in Europe to clear the drug

Timeline cronologica

lunedì 10 agosto 2026·dailymail.com
Another weight loss tablet approved for use in UK
Orforglipron, a once-daily tablet produced by the same manufacturers as Mounjaro, has been given the green light by British health officials.
lunedì 10 agosto 2026·politiken.dk
Novo-rival får lov til at sælge sin vægttabspille i Storbrit
Storbritannien er det første europæiske land til at godkende selskabet Eli Lillys vægttabspille.

independent.co.uk

2 g fa

New once-daily weight loss pill approved by the UK medicines regulator

The UK has become the first country in Europe to authorise orforglipron, known as Foundayo

Leggi questa versione → originale

economictimes.indiatimes.com1 g fa

UK first in Europe to approve Eli Lilly oral weight loss drug

Britain has become the first country in Europe to approve orforglipron, the oral weight loss and diabetes treatment developed by US company Eli Lilly, the UK government has revealed. Eli Lilly's Mounjaro weight loss…

Leggi questa versione → originale

Eli Lilly takes weight-loss pill battle global with first Foundayo approval outside U.S.

Lilly's Foundayo wins U.K. approval, taking its weight-loss pill battle with Novo Nordisk's Wegovy beyond the U.S. market.

Leggi questa versione → originale

lemonde.fr1 g fa

Pilule antiobésité : le Foundayo, développé par le laboratoire américain Eli Lilly, autorisé au Royaume-Uni,…

Cette version en comprimé du médicament contre l’obésité et le diabète sera soumise à prescription médicale. Le groupe danois Novo Nordisk a déjà obtenu l’autorisation pour le comprimé Wegovy au Royaume-Uni, mais aussi…

Leggi questa versione → originale

dailymail.com2 g fa

Another weight loss tablet approved for use in UK

Orforglipron, a once-daily tablet produced by the same manufacturers as Mounjaro, has been given the green light by British health officials.

Leggi questa versione → originale

lunedì 10 agosto 2026·

independent.co.uk

New once-daily weight loss pill approved by the UK medicines regulator

The UK has become the first country in Europe to authorise orforglipron, known as Foundayo

lunedì 10 agosto 2026·

independent.co.uk

UK medicines regulator approves new weight loss pill

Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged…

lunedì 10 agosto 2026·

valor.globo.com

Regulador britânico autoriza venda do comprimido de perda de peso da Eli Lilly

Comprimido Foundayo, de dose diária, é baseado em uma substância análoga à enzima GLP-1 da farmacêutica americana

lunedì 10 agosto 2026·

clarin.com

Reino Unido aprueba el orforglipron: todo lo que se sabe sobre la nueva píldora para adelgazar y mantener el peso “de por vida”

La mayor diferencia entre el nuevo medicamento que lo diferencia de tratamientos como Ozempic o Mounjaro.¿Cuánto tiempo habrá que tomarlo para evitar recuperar los kilos?

martedì 11 agosto 2026·

economictimes.indiatimes.com

Eli Lilly’s Foundayo becomes first oral weight-loss drug approved in UK for diabetes

Britain's regulator approved Eli Lilly's Foundayo pill for weight and diabetes. This treatment is not yet available through the NHS in the UK. Foundayo will launch privately…

martedì 11 agosto 2026·

letemps.ch

Le Royaume-Uni autorise l’orforglipron, premier comprimé anti-obésité d’Eli Lilly approuvé en Europe - Le Temps

La molécule orforglipron, qui se prend une fois par jour sans contrainte alimentaire, concurrence les injections comme Mounjaro. Elle reste soumise à prescription et devra être…

martedì 11 agosto 2026·

hotnews.ro

Foundayo, pilula pentru slăbit cu un avantaj major, a fost aprobată în premieră în Europa - HotNews.ro

Autoritatea britanică de reglementare a medicamentelor a autorizat luni comercializarea Foundayo, pilula pentru controlul greutății și tratarea diabetului de

martedì 11 agosto 2026·

cnbc.com

Eli Lilly takes weight-loss pill battle global with first Foundayo approval outside U.S.

Lilly's Foundayo wins U.K. approval, taking its weight-loss pill battle with Novo Nordisk's Wegovy beyond the U.S. market.

martedì 11 agosto 2026·

independent.co.uk

Foundayo: The new weight loss pill approved for the UK

Foundayo has been approved for treating weight loss as well as type 2 diabetes

martedì 11 agosto 2026·

independent.co.uk

What we know about Foundayo - the new weight loss pills to be approved in UK

Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged…

martedì 11 agosto 2026·

economictimes.indiatimes.com

UK first in Europe to approve Eli Lilly oral weight loss drug

Britain has become the first country in Europe to approve orforglipron, the oral weight loss and diabetes treatment developed by US company Eli Lilly, the UK government has…

martedì 11 agosto 2026·

lemonde.fr

Pilule antiobésité : le Foundayo, développé par le laboratoire américain Eli Lilly, autorisé au Royaume-Uni, une première en Europe

Cette version en comprimé du médicament contre l’obésité et le diabète sera soumise à prescription médicale. Le groupe danois Novo Nordisk a déjà obtenu l’autorisation pour le…

martedì 11 agosto 2026·

qz.com

Eli Lilly's Foundayo weight-loss pill approved in the U.K.

The U.K. regulator authorized orforglipron for weight management and type 2 diabetes, making Britain the first country in Europe to clear the drug

martedì 11 agosto 2026·

ansa.it

Gb è primo Paese in Europa ad approvare la pillola dimagrante - Alimentazione - Ansa.it

Il Regno Unito è il primo Paese in Europa ad approvare la messa in commercio dell'orforglipron, il principio attivo alla base di un farmaco contro obesità e diabete. (ANSA)

martedì 11 agosto 2026·

g4media.ro

Pastile împotriva obezității: Foundayo a fost autorizat în Regatul Unit, o premieră în Europa

Laboratorul american Eli Lilly a obținut autorizația de introducere pe piață în Regatul Unit a orforglipronului, un comprimat din clasa GLP-1 destinat tratării obezității și…

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com